Non-Small Cell Lung Cancer Clinical Trials

A listing of 141 Non-Small Cell Lung Cancer clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Non-Small Cell Lung Cancer

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 141 active clinical trials seeking participants for Non-Small Cell Lung Cancer research studies. The states with the highest number of trials for Non-Small Cell Lung Cancer participants are California, Texas, Florida and New York.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

NCT06561386

Recruiting

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/16/2025

Locations: Local Institution - 0368, Tucson, Arizona +272 locations

Local Institution - 0368, Tucson, Arizona

Local Institution - 0112, Los Angeles, California

Local Institution - 0304, Sacramento, California

San Francisco Oncology Associates, San Francisco, California

UCLA Hematology/Oncology - Santa Monica, Santa Monica, California

University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami, Florida

Memorial Hospital West, Pembroke Pines, Florida

Florida Cancer Specialists - North, Saint Petersburg, Florida

Florida Cancer Specialists - East, West Palm Beach, Florida

Affiliated Oncologists, LLC, Chicago Ridge, Illinois

Saint Elizabeth Medical Center Edgewood, Edgewood, Kentucky

Hattiesburg Clinic Hematology/Oncology, Hattiesburg, Mississippi

Bozeman Health Deaconess Hospital, Bozeman, Montana

Renown Regional Medical Center, Reno, Nevada

St. Joseph's Regional Medical Center, Paterson, New Jersey

New Mexico VA Healthcare System, Albuquerque, New Mexico

Local Institution - 0357, Bronx, New York

Local Institution - 0356, Hawthorne, New York

Local Institution - 0392, New York, New York

Local Institution - 0380, Northport, New York

Local Institution - 0325, Rochester, New York

Local Institution - 0324, Syracuse, New York

Messino Cancer Centers, Asheville, North Carolina

Local Institution - 0351, Greenville, North Carolina

Local Institution - 0369, Canton, Ohio

University of Cincinnati Medical Center, Cincinnati, Ohio

Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio

Local Institution - 0366, Massillon, Ohio

Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster, Pennsylvania

Texas Oncology - West Texas, Abilene, Texas

Local Institution - 0305, Harlingen, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center, Tyler, Texas

Local Institution - 0302, Salt Lake City, Utah

Local Institution - 0379, Ciudad autónoma de Buenos Aires, Buenos Aires

Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires

Hospital Italiano de Buenos Aires, ABB, Ciudad Autónoma De Buenos Aires

Instituto Médico Río Cuarto, Río Cuarto, Córdoba

Sanatorio Parque, Rosario, Santa Fe

Hospital Privado Universitario de Córdoba, Córdoba, Not set

Local Institution - 0370, Córdoba, Not set

Hospital Privado de Comunidad, Mar del Plata, Not set

Gosford Hospital, Gosford, New South Wales

GenesisCare North Shore, St Leonards, New South Wales

The Prince Charles Hospital, Brisbane, Queensland

Gallipoli Medical Research Ltd, Brisbane, Queensland

Local Institution - 0057, Elizabeth Vale, South Australia

Box Hill Hospital, Box Hill, Victoria

Fiona Stanley Hospital, Murdoch, Western Australia

St. John of God Murdoch Hospital, Murdoch, Western Australia

Local Institution - 0314, Krems, Niederösterreich

Local Institution - 0292, Wels, Oberösterreich

Local Institution - 0293, Wien, Not set

Local Institution - 0396, Edegem, Antwerpen

Local Institution - 0039, Brussels, Bruxelles-Capitale, Région De

Local Institution - 0187, Hasselt, Limburg

Local Institution - 0038, Yvoir, Namur

Local Institution - 0041, Roeselare, West-Vlaanderen

Local Institution - 0185, Liège, Not set

Pronutrir, Fortaleza, Ceará

Cetus Oncologia - Unidade Belo Horizonte, Belo Horizonte, Minas Gerais

Local Institution - 0375, Belem, Pará

Local Institution - 0151, Natal, Rio Grande Do Norte

Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul

Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul

Clínica de Neoplasias Litoral, Itajaí, Santa Catarina

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo

NAIC - Instituto do Câncer, Bauru, São Paulo

Centro de Oncologia - CEON+ - Unidade São Caetano do Sul, São Caetano do Sul, São Paulo

Instituto Nacional de Câncer - INCA, Rio de Janeiro, Not set

Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo, Not set

Orlandi Oncologia, Santiago, Región Metropolitana De Santiago

Fundacion Arturo Lopez Perez (FALP), Santiago, Región Metropolitana De Santiago

Pontificia Universidad Catolica de Chile, Santiago, Región Metropolitana De Santiago

Bradfordhill, Santiago, Región Metropolitana De Santiago

Oncocentro Apys, Viña del Mar, Valparaíso

Local Institution - 0182, Hefei, Anhui

Beijing Cancer hospital, Beijing, Beijing

Chongqing University Cancer Hospital, Chongqing, Chongqing

Chongqing Three Gorges Central Hospital, Wanzhou, Chongqing

Fujian Cancer Hospital, Fuzhou, Fujian

Local Institution - 0307, Guangzhou, Guangdong

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

Huizhou Central People's Hospital, Huizhou, Guangdong

Liuzhou People's Hospital, Liuzhou, Guangxi

Guangxi Medical University Affiliated Tumor Hospital, Nanning, Guangxi

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang

Local Institution - 0420, Xinxiang, Henan

The First Affiliated Hospital of Zhengzhou Universtiy, Zhengzhou, Henan

Local Institution - 0235, Wuhan, Hubei

Hunan Cancer Hospital, Changsha, Hunan

First Huai'an Hospital Affiliated to Nanjing Medical University, Huai'an, Jiangsu

Local Institution - 0451, Nanchang, Jiangxi

Liaoning Cancer Hospital, Shenyang, Liaoning

Xi'an International Medical Center Hospital, Xi'an, Shaanxi

Shandong Cancer Hospital, Jinan, Shandong

Shanghai Chest Hospital, Shanghai, Shanghai

Zhongshan Hospital,Fudan University, Shanghai, Shanghai

Local Institution - 0435, Taiyuan, Shanxi

Sichuan Cancer hospital, Chengdu, Sichuan

The Second People's Hospital of Neijiang, Neijiang, Sichuan

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin

The first Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang

Local Institution - 0415, Medellín, Antioquia

Local Institution - 0417, Valledupar, Cesar

Local Institution - 0443, Bogotá, Distrito Capital De Bogotá

Local Institution - 0418, Bogotá, Distrito Capital De Bogotá

Local Institution - 0416, Pereira, Risaralda

Local Institution - 0442, Cali, Valle Del Cauca

Local Institution - 0198, Aarhus, Midtjylland

Local Institution - 0124, Soenderborg, Syddanmark

Local Institution - 0125, Copenhagen, Not set

Local Institution - 0090, Toulouse, Haute-Garonne

Local Institution - 0092, Montpellier, Hérault

Local Institution - 0093, Rennes, Ille-et-Vilaine

Local Institution - 0395, Vandoeuvre lès Nancy, Meurthe-et-Moselle

Local Institution - 0096, Lille, Nord-Pas-de-Calais

Local Institution - 0091, Toulon, Provence-Alpes-Côte-d'Azur

Local Institution - 0157, Pierre-Bénite, Rhône

Local Institution - 0421, Bayonne, Not set

Local Institution - 0158, Marseille, Not set

Local Institution - 0089, Paris, Not set

Local Institution - 0095, Paris, Not set

Local Institution - 0284, Esslingen, Baden-Württemberg

Local Institution - 0439, Ulm, Baden-Württemberg

Local Institution - 0287, Kempten, Bayern

Local Institution - 0347, München, Bayern

Local Institution - 0313, Marburg, Hessen

Local Institution - 0436, Hannover, Niedersachsen

Local Institution - 0397, Herne, Nordrhein-Westfalen

Local Institution - 0438, Münster, Nordrhein-Westfalen

Local Institution - 0437, Chemnitz, Sachsen

Local Institution - 0316, Grosshansdorf, Schleswig-Holstein

Local Institution - 0285, Berlin, Not set

Local Institution - 0282, Bonn, Not set

Local Institution - 0288, Essen, Not set

Local Institution - 0286, Gauting, Not set

Local Institution - 0329, New Delhi, Delhi

Local Institution - 0448, New Delhi, Delhi

Local Institution - 0337, New Delhi, Delhi

Local Institution - 0333, Bengaluru, Karnataka

Local Institution - 0331, Thiruvananthapuram, Kerala

Local Institution - 0446, Mumbai, Maharashtra

Local Institution - 0336, Mumbai, Maharashtra

Local Institution - 0453, Secunderabad, Telangana

Local Institution - 0328, Howrah, West Bengal

Local Institution - 0367, Dublin, Not set

Local Institution - 0028, Dublin, Not set

Local Institution - 0029, Dublin, Not set

Local Institution - 0027, Dublin, Not set

Local Institution - 0400, Ravenna, Emilia-Romagna

Local Institution - 0045, Monza, Lombardia

Local Institution - 0046, Naples, Napoli

Local Institution - 0049, Naples, Napoli

Local Institution - 0043, Bari, Puglia

Local Institution - 0250, Rome, Roma

Local Institution - 0221, Peschiera del Garda, Verona

Local Institution - 0222, Ravenna, Not set

Local Institution - 0312, Kashiwa, Chiba

University of Occupational and Enviromental Health, Kitakyushu, Fukuoka

Kurume University Hospital, Kurume, Fukuoka

Chugoku Central Hospital, Fukuyama-shi, Hiroshima

National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido

Local Institution - 0449, Yokohama, Kanagawa

Kanagawa cancer center, Yokohama, Kanagawa

Local Institution - 0444, Nankoku, Kochi

Sendai Kousei Hospital, Sendai, Miyagi

Nara Medical University Hospital, Kashihara, Nara

Niigata Cancer Center Hospital, Niigata-shi, Niigata

Kurashiki Central Hospital, Kurashiki, Okayama

Kansai Medical University Hospital, Hirakata, Osaka

Kindai University Hospital- Osakasayama Campus, Osaka-sayama, Osaka

Saitama Medical University International Medical Center, Hidaka, Saitama

Hamamatsu University Hospital, Hamamatsu, Shizuoka

Shizuoka Cancer Center, Nagaizumi-cho,Sunto-gun, Shizuoka

The Cancer Institute Hospital of JFCR, Koto, Tokyo

Hyogo Cancer Center, Akashi, Not set

Fukushima Medical University, Fukushima, Not set

Osaka International Cancer Institute, Osaka, Not set

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]

Gachon University Gil Medical Center, Namdong-gu, Incheon-gwangyeoksi [Incheon]

Local Institution - 0458, Hwasun, Jeonranamdo

National Cancer Center, Goyang-si, Kyǒnggi-do

Local Institution - 0450, Seongnam-si, Kyǒnggi-do

Local Institution - 0454, Busan, Pusan-Kwangyǒkshi

Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]

Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0170, Guadalajara, Jalisco

Local Institution - 0168, Santiago de Queretaro, Querétaro

Local Institution - 0172, Mexico, Not set

Local Institution - 0169, San Luis Potosí, Not set

Local Institution - 0030, Harderwijk, Gelderland

Local Institution - 0193, Heerlen, Limburg

Local Institution - 0196, Den Bosch, Noord-Brabant

Local Institution - 0195, Zwolle, Overijssel

Local Institution - 0036, Leiden, Zuid-Holland

Local Institution - 0315, The Hague, Zuid-Holland

Local Institution - 0033, Arnhem, Not set

Local Institution - 0032, Groningen, Not set

Local Institution - 0407, Tauranga, Bay Of Plenty

Local Institution - 0447, Tauranga, Bay Of Plenty

Local Institution - 0405, Auckland, Not set

Local Institution - 0425, Dunedin, Not set

Local Institution - 0406, Wellington, Not set

Local Institution - 0259, Warsaw, Mazowieckie

Local Institution - 0258, Prabuty, Pomorskie

Local Institution - 0255, Konin, Wielkopolskie

Local Institution - 0261, Poznan, Wielkopolskie

Local Institution - 0256, Poznań, Wielkopolskie

Local Institution - 0257, Koszalin, Zachodniopomorskie

Local Institution - 0260, Bydgoszcz, Not set

Local Institution - 0254, Łódź, Łódzkie

Local Institution - 0402, Lisbon, Lisboa

Local Institution - 0404, Coimbra, Not set

Local Institution - 0403, Porto, Not set

Local Institution - 0401, Porto, Not set

Local Institution - 0296, Bucharest, București

Local Institution - 0298, Bucharest, București

Local Institution - 0299, Florești, Cluj

Local Institution - 0295, Craiova, Dolj

Local Institution - 0297, Ploiești, Prahova

Local Institution - 0301, Cluj, Not set

Local Institution - 0300, Iași, Not set

Local Institution - 0408, Riyadh, Ar Riyāḑ

Local Institution - 0440, Dammam, Ash Sharqīyah

Local Institution - 0409, Jeddah, Makkah Al Mukarramah

Local Institution - 0429, Johannesburg, GP

Local Institution - 0432, Pretoria, GP

Local Institution - 0427, Sandton, GP

Local Institution - 0431, Soweto, GP

Local Institution - 0428, Cape Town, Western Cape

Local Institution - 0270, A Coruña, A Coruña [La Coruña]

Local Institution - 0264, Barcelona, Barcelona [Barcelona]

Local Institution - 0434, Barcelona, Catalunya [Cataluña]

Local Institution - 0267, L'Hospitalet de Llobregat, Catalunya [Cataluña]

Local Institution - 0414, Palma, Illes Balears [Islas Baleares]

Local Institution - 0413, Madrid, Madrid, Comunidad De

Local Institution - 0265, Madrid, Madrid, Comunidad De

Local Institution - 0426, Majadahonda, Madrid, Comunidad De

Local Institution - 0411, Valencia, València

Local Institution - 0266, Málaga, Not set

Local Institution - 0268, Sevilla, Not set

Local Institution - 0269, València, Not set

Local Institution - 0341, Bellinzona, Ticino

Local Institution - 0291, Lausanne, Vaud

Local Institution - 0290, Basel, Not set

Local Institution - 0398, Münsterlingen, Not set

Local Institution - 0445, Kaohsiung Niao Sung Dist, Kaohsiung

Taipei Medical University Shuang Ho Hospital, New Taipei, Not set

Taichung Veterans General Hospital, Taichung, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Local Institution - 0361, Adana, Not set

Local Institution - 0365, Adana, Not set

Local Institution - 0383, Ankara, Not set

Local Institution - 0362, Ankara, Not set

Local Institution - 0410, Istanbul, Not set

Local Institution - 0364, Istanbul, Not set

Local Institution - 0441, Exeter, Devon

Ninewells Hospital and Medical School, Dundee, Dundee City

Forth Valley Royal Hospital, Larbert, Falkirk

Local Institution - 0189, Glasgow, Glasgow City

Local Institution - 0021, London, Kensington And Chelsea

St Bartholomew's Hospital, London, London, City Of

Local Institution - 0001, London, London, City Of

Local Institution - 0020, Manchester, Not set

Local Institution - 0024, Wirral, Not set

Conditions: Non-small Cell Lung Cancer

Learn More ›

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06568939

Recruiting

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. The purpose of this study is to assess how safe telisotuzumab vedotin is in adult participants with NSCLC. Change in disease activity and adverse events will be assessed. Telisotuzumab vedotin is an investigational drug being developed for the treatment of NSCLC. Participants will be... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/16/2025

Locations: Yale New Haven Hospital /ID# 271584, New Haven, Connecticut +32 locations

Yale New Haven Hospital /ID# 271584, New Haven, Connecticut

Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 270899, Jacksonville, Florida

Ocala Oncology Center /ID# 273697, Ocala, Florida

Comprehensive Hematology Oncology /ID# 270422, Saint Petersburg, Florida

Florida Cancer Specialists - North /ID# 271995, Saint Petersburg, Florida

Florida Cancer Specialists - East /ID# 271993, West Palm Beach, Florida

University Cancer & Blood Center /ID# 270969, Athens, Georgia

Springfield Clinic /ID# 272576, Springfield, Illinois

NHO - Nebraska Hematology-Oncology /ID# 272970, Lincoln, Nebraska

Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271527, Omaha, Nebraska

Astera Cancer Care /ID# 272359, East Brunswick, New Jersey

Clinical Research Alliance - Westbury /ID# 270455, Westbury, New York

FirstHealth of the Carolinas- Speciality Center /ID# 272924, Pinehurst, North Carolina

Mercy Health - Perrysburg Cancer Center /ID# 270536, Perrysburg, Ohio

Genesis Healthcare System /ID# 273361, Zanesville, Ohio

Guthrie Robert Packer Hospital /ID# 270316, Sayre, Pennsylvania

Cancer Care Associates Of York /ID# 270971, York, Pennsylvania

SCRI Oncology Partners /ID# 270162, Nashville, Tennessee

Texas Oncology - Northeast Texas /ID# 272000, Tyler, Texas

Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax, Virginia

Northwest Medical Specialties Tacoma /ID# 270534, Tacoma, Washington

Beijing Chest Hospital, Capital Medical University /ID# 271935, Beijing, Beijing

Affiliated Cancer Hospital of Guangxi Medical University /ID# 271931, Nanning, Guangxi

Union Hospital - Tongji Medical College /ID# 271668, Wuhan, Hubei

The First Affiliated Hospital of Nanchang University /ID# 271666, Nanchang, Jiangxi

The First Affiliated Hospital of Xi'an Jiaotong University /ID# 271928, Xian, Shaanxi

Linyi Cancer Hospital /ID# 272068, Linyi, Shandong

Rambam Health Care Campus /ID# 270078, Haifa, H_efa

Meir Medical Center /ID# 270071, Kfar Saba, HaMerkaz

Shaare Zedek Medical Center /ID# 270095, Jerusalem, Not set

Rabin Medical Center /ID# 270087, Petah Tikva, Not set

National Cancer Centre Singapore /ID# 271499, Singapore, Central Singapore

National University Hospital /ID# 271700, Singapore, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

NCT06586515

Recruiting

The main purpose of this study is to assess safety \& tolerability and antitumor activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in participants with KRAS G12D-mutant advanced solid tumor types. The study is expected to last approximately 5 years.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/16/2025

Locations: City of Hope, Duarte, California +51 locations

City of Hope, Duarte, California

University of California, Los Angeles (UCLA), Los Angeles, California

Sarah Cannon Research Institute at HealthOne, Denver, Colorado

Sibley Memorial Hospital, Washington DC, District of Columbia

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando, Florida

Emory University School of Medicine, Atlanta, Georgia

Community Health Network, Indianapolis, Indiana

Massachusetts General Hospital, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan

New York University (NYU) Langone Medical Center, New York, New York

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York

Duke University Medical Center, Durham, North Carolina

University of Cincinnati (UC) - Cancer Institute, Cincinnati, Ohio

Cleveland Clinic, Cleveland, Ohio

University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center, Pittsburgh, Pennsylvania

Sarah Cannon Research Institute, Nashville, Tennessee

USO - US Oncology Research Network, Nashville, Tennessee

Vanderbilt University School of Medicine, Nashville, Tennessee

MD Anderson Cancer Center, Houston, Texas

South Texas Accelerated Research Therapeutics (START), San Antonio, Texas

Huntsman Cancer Institute, Salt Lake City, Utah

Fred Hutchinson Cancer Center, Seattle, Washington

University of Wisconsin - Carbone Cancer Center, Madison, Wisconsin

The Ottawa Hospital, Ottawa, Ontario

Princess Margaret Hospital, Toronto, Ontario

Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, Not set

Beijing Cancer hospital, Beijing, Not set

Harbin Medical University Cancer Hospita, Harbin, Not set

Fudan University Cancer Center, Shanghai, Not set

Centre Leon Berard, Lyon, Not set

Centre d'Essais Precoces en Cancerologie de Marseille (CEPCM) - AP-HM Hopital de La Timone, Marseille, Not set

Oncopole Claudius Regaud, Toulouse, Not set

Institut Gustave Roussy, Villejuif cedex, Not set

Charite Universitaetsmedizin Berlin, Berlin, Not set

Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Not set

Universitaetsklinikum Essen, Essen, Not set

Klinikum der Ludwig-Maximilians-Universitaet Muenchen, Munchen, Not set

START Dublin Early Phase Clinical Trials Unit, Dublin, Not set

Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli, Napoli, Not set

UOC Fase I - Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Not set

Centro Ricerche Cliniche di Verona s.r.l., Verona, Not set

Kanagawa cancer center, Kanagawa, Not set

National Cancer Center Hospital East, Kashiwa, Chiba, Not set

Aichi Cancer Center Hospital, Nagoya, Not set

Kansai Medical University Hospital, Osaka, Not set

National Cancer Center Hospital, Tokyo, Not set

South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos, Barcelona, Not set

Hospital Universitario Vall d'Hebron, Barcelona, Not set

South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Conditions: Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer

Learn More ›

Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

NCT02146170

Recruiting

Background: - Lung cancer is the leading cause of cancer-related death worldwide. It causes more than one million deaths every year. Researchers want to gather tissue samples from people with lung and thymic cancers to understand the disease better. This may lead to new ways to diagnose and treat it. Objective: - To collect tissue samples for use in the study of lung cancers. Eligibility: - Adults over age 18 with non-small cell lung cancer, small cell lung cancer, extra pulmonary small cel... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/13/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, Thymic Epithelial Tumors

Learn More ›

A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer

NCT04302025

Recruiting

This trial will evaluate the efficacy and safety of various therapies in patients with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) tumors that meet protocol-specified biomarker criteria

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/13/2025

Locations: City of Hope Comprehensive Cancer Center, Duarte, California +38 locations

City of Hope Comprehensive Cancer Center, Duarte, California

City of Hope - Orange County Lennar Foundation Cancer Center, Irvine, California

USC Norris Cancer Center, Los Angeles, California

Cedars-Sinai Medical Center, Los Angeles, California

University of California Los Angeles - Jonsson Comprehensive Cancer Center, Los Angeles, California

The Center for Cancer Prevention and Treatment at St.Joseph Hospital of Orange, Orange, California

UC Davis Comprehensive Cancer Center, Sacramento, California

UCSF Helen Diller Family CCC, San Francisco, California

University of Colorado - Anschutz Medical Campus (University of Colorado Health Sciences Center), Aurora, Colorado

Yale Cancer Center, New Haven, Connecticut

MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington, District of Columbia

Moffitt Cancer Center, Tampa, Florida

Northwestern University, Chicago, Illinois

Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois

Northwestern Medicine Cancer Center Delnor, Geneva, Illinois

Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois

Boston Medical Center, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

University of Michigan, Ann Arbor, Michigan

Karmanos Cancer Institute - Farmington Hills/Weisberg Cancer Treatment Center, Farmington Hills, Michigan

Mayo Clinic, Rochester, Minnesota

Ellis Fischel Cancer Center, Columbia, Missouri

Siteman Cancer Center - Washington University Medical Campus, Saint Louis, Missouri

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Laura and ISAAC Perlmutter Cancer Center at NYU Langone., New York, New York

Columbia University Medical Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Ohio State University, Columbus, Ohio

AHN Cancer Institute ? Allegheny General Hospital, Pittsburgh, Pennsylvania

Baptist Clinical Research Institute, Memphis, Tennessee

Tennessee Oncology - Nashville, Nashville, Tennessee

Kelsey Seybold Clnic, Houston, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Baylor College of Medicine, Houston, Texas

Lumi Research, Kingwood, Texas

Virginia Cancer Specialists (Fairfax) - USOR, Fairfax, Virginia

Seattle Cancer Care Alliance, Seattle, Washington

Conditions: Non-small Cell Lung Cancer

Learn More ›

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT06120283

Recruiting

This is a dose escalation and dose expansion study to compare how well BGB-43395, a selective cyclin-dependent kinase 4 (CDK4) inhibitor, works as monotherapy or in combination with fulvestrant, letrozole, or elacestrant in participants with hormone receptor positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. The main purpose of this study is to explore the recommended dosing for BGB-43395.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/13/2025

Locations: Sarah Cannon Research Institute (Scri) At Health One, Denver, Colorado +62 locations

Sarah Cannon Research Institute (Scri) At Health One, Denver, Colorado

Florida Cancer Specialists and Research Institute, Lake Mary, Florida

Karmanos Cancer Institute, Detroit, Michigan

Washington University School of Medicine, Saint Louis, Missouri

Duke Cancer Center, Durham, North Carolina

James Cancer Hospital and Solove Research Institute, Columbus, Ohio

Scri Oncology Partners, Nashville, Tennessee

The University of Texas Md Anderson Cancer Center, Houston, Texas

Next Dallas, Irving, Texas

Next Oncology, San Antonio, Texas

Blacktown Cancer and Haematology Centre, Blacktown, New South Wales

Southern Highlands Private Hospital, Bowral, New South Wales

Concord Repatriation General Hospital, Concord, New South Wales

Macquarie University, North Ryde, New South Wales

Townsville University Hospital, Douglas, Queensland

Genesiscare St Andrews, Adelaide, South Australia

Austin Health, Heidelberg, Victoria

Peter Maccallum Cancer Centre, Melbourne, Victoria

Fundacao Pio Xii Hospital de Amor de Barretos, Barretos, Not set

Hospital Sirio Libanes Brasilia, Brasilia, Not set

Centro de Pesquisas Oncologicas Cepon, Florianopolis, Not set

Liga Norte Riograndene Contra O Cancer, Natal, Not set

Fundacao Universidade de Caxias Do Sul Instituto de Pesquisas Em Saude, Petropolis, Not set

Hospital Sao Lucas Da Pucrs Uniao Brasileira de Educacao E Assistencia, Porto Algre, Not set

Instituto Nacional de Cancer, Rio de Janeiro, Not set

Instituto Dor de Pesquisa E Ensino Hospital Sao Rafael, Salvador, Not set

Icesp Instituto Do Cancer Do Estado de Sao Paulo Octavio Frias de Oliveira, Sao Paulo, Not set

Clinica de Pesquisa E Centro de Estudos Em Oncologia Ginecologica E Mamaria, Sao Paulo, Not set

Hospital Israelita Albert Einstein, Sao Paulo, Not set

Beijing Cancer Hospital, Beijing, Beijing

Fujian Cancer Hospital, Fuzhou, Fujian

Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou, Guangdong

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang

The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi

Liaoning Cancer Hospital and Institute, Shenyang, Liaoning

Fudan University Shanghai Cancer Centerpudong, Shanghai, Shanghai

Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux, Not set

Centre Francois Baclesse, Caen, Not set

Centre Oscar Lambret, Lille, Not set

Institut Paoli Calmettes, Marseille, Not set

Institut Curie, Paris, Not set

Centre Eugene Marquis, Rennes, Not set

Institut de Cancerologie de Louest, St Herblain, Not set

Institut Gustave Roussy, Villejuif, Not set

Nagoya University Hospital, Nagoya, Aichi

National Cancer Center Hospital East, Kashiwa, Chiba

Shizuoka Cancer Center, Suntogun, Shizuoka

Seoul National University Bundang Hospital, BundangGu SeongnamSi, Gyeonggi-do

Korea University Anam Hospital, SeongbukGu, Gyeonggi-do

Gachon University Gil Medical Center, NamdongGu, Incheon Gwang'yeogsi

Samsung Medical Center, GangnamGu, Seoul Teugbyeolsi

The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi

Severance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi

Seoul National University Hospital, Seoul, Seoul Teugbyeolsi

Asan Medical Center, SongpaGu, Seoul Teugbyeolsi

Pulau Pinang Hospital, Georgetown, Not set

University Malaya Medical Centre, Kuala Lumpur, Not set

Sarawak General Hospital, Kuching, Not set

National Cancer Institute (Institut Kanser Negara), Putrajaya, Not set

The Institute of Oncology, Arensia Exploratory Medicine, Chisinau, Not set

Harbour Cancer and Wellness, Auckland, Not set

Nzcr Christchurch, Christchurch, Not set

Srinagarind Hospital (Khon Kaen University), Muang, Not set

Conditions: Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Hormone Receptor Positive Malignant Neoplasm of Breast, HER2-negative Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Non-small Cell Lung Cancer

Learn More ›

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT02682667

Recruiting

Background: Cancer has a major impact in the United States and across the world. In 2015, over 1.5 million new cases of cancer were diagnosed in the U.S. Researchers want to study samples from people with cancer or a pre-malignant condition. They hope to develop more effective treatments. Objective: To better understand the biology of malignancies and why certain cancers respond differently to treatment. Eligibility: Adults at least 18 years old with cancer or a pre-cancerous condition. De... Read More

Gender:

ALL

Ages:

Between 18 years and 120 years

Trial Updated:

06/13/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Multiple Myeloma, Lymphoma, Non-Hodgkin, Leukemia-Lymphoma, Adult T-Cell, Hodgkin Disease, Non-Small Cell Lung Cancer

Learn More ›

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

NCT05267626

Recruiting

This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be administered either as a monotherapy, or in combination with a single loading dose of aldesleukin, or with both AU-007 and aldesleukin given every 2 weeks (Q2w). Once the recommended phase 2 dose (RP2D) of AU-007 plus aldesleukin was determined, (AU-007 Q2w plus a single loading dose of aldesleukin), AU-00... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/12/2025

Locations: START Midwest, Grand Rapids, Michigan +12 locations

Conditions: Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma, Non-Small Cell Lung Cancer

Learn More ›

A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)

NCT06333678

Recruiting

In this study, the researchers will look at whether having participants switch from durvalumab to sotorasib when they have detectable minimal residual disease (MRD) is an effective treatment approach for locally advanced non-small cell lung cancer (LA-NSCLC). The researchers will see whether this switch to sotorasib can control LANSCLC longer compared to the treatment approach of staying on durvalumab (and not switching to sotorasib).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/12/2025

Locations: University of Miami (Data Collection Only), Miami, Florida +10 locations

Conditions: Non-Small Cell Lung Cancer

Learn More ›

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

NCT06238479

Recruiting

The purpose of this study is to find out whether the study drug, LY4101174, is safe, tolerable and effective in participants with select advanced or metastatic solid tumors. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-expansion). The study will last up to approximately 4 years.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/12/2025

Locations: AdventHealth Orlando, Orlando, Florida +24 locations

AdventHealth Orlando, Orlando, Florida

Emory University, Atlanta, Georgia

Massachusetts General Hospital, Boston, Massachusetts

Washington University School of Medicine, St. Louis, Missouri

Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

UT Southwestern Medical Center, Dallas, Texas

South Texas Accelerated Research Therapeutics (START), San Antonio, Texas

Icon Cancer Centre Kurralta Park, Kurralta Park, South Australia

Austin Health, Heidelberg, Victoria

Institut Jules Bordet, Anderlecht, Bruxelles-Capitale, Région de

Centre Oscar Lambret, Lille, Nord-Pas-de-Calais

Institut de cancérologie Strasbourg Europe, Strasbourg, Strasbourg, Alsace

Centre Leon Berard, Lyon Cedex 08, Not set

Institut Paoli-Calmettes, Marseille, Not set

Gustave Roussy, Villejuif Cedex, Not set

National Cancer Center Hospital East, Kashiwa, Chiba

The Cancer Institute Hospital of JFCR, Koto City, Tokyo

National Cancer Center Hospital, Chuo-Ku, Not set

Kyoto University Hospital, Kyoto, Not set

Hospital Universitari Vall d'Hebron, Barcelona, Not set

MD Anderson Cancer Center, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Conditions: Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm, Triple Negative Breast Cancer, Non-small Cell Lung Cancer, Esophageal Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Prostate Cancer, Renal Pelvis Cancer, Bladder Cancer

Learn More ›

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

NCT06077760

Recruiting

The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin negative, completely resected Stage II, IIIA, IIIB (with nodal involvement \[N2\]) non-small cell lung cancer (NSCLC). The primary hypothesis is that intismeran autogene plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS) as assessed by the investigator.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/12/2025

Locations: Alaska Oncology and Hematology ( Site 0039), Anchorage, Alaska +192 locations

Alaska Oncology and Hematology ( Site 0039), Anchorage, Alaska

YUMA REGIONAL MEDICAL CENTER CANCER CENTER ( Site 0020), Yuma, Arizona

UCLA Clinical & Translational Research Center (CTRC) ( Site 0059), Los Angeles, California

St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0074), Orange, California

University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0030), Orange, California

UCHealth Memorial Hospital-Heme Onc ( Site 0052), Colorado Springs, Colorado

Mid Florida Hematology and Oncology Center ( Site 0014), Orange City, Florida

AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlandoc ( Site 0013), Orlando, Florida

Moffitt Cancer Center ( Site 0078), Tampa, Florida

Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0012), Marietta, Georgia

Southeastern Regional Medical Center ( Site 0098), Newnan, Georgia

Beacon Cancer Care ( Site 0044), Post Falls, Idaho

University of Iowa-Holden Comprehensive Cancer Center ( Site 0062), Iowa City, Iowa

Saint Elizabeth Healthcare ( Site 0092), Edgewood, Kentucky

The University of Louisville, James Graham Brown Cancer Center ( Site 0037), Louisville, Kentucky

University of Michigan Clinical Trials Office ( Site 0058), Ann Arbor, Michigan

Cancer and Hematology Centers of Western Michigan ( Site 4003), Grand Rapids, Michigan

St. Vincent Frontier Cancer Center ( Site 0043), Billings, Montana

NHO Revive Research Institute, LLC ( Site 4009), Lincoln, Nebraska

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0036), Hackensack, New Jersey

New York Oncology Hematology, P.C. ( Site 4012), Albany, New York

Montefiore Medical Center- Montefiore Medical Park-Oncology ( Site 0080), Bronx, New York

Perlmutter Cancer Center at NYU Langone Hospital - Long Island-Clinical Research Department ( Site 0095), Mineola, New York

Laura and Isaac Perlmutter Cancer Center ( Site 0010), New York, New York

Icahn School of Medicine at Mount Sinai ( Site 0034), New York, New York

Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical ( Site 0054), New York, New York

Memorial Sloan Kettering Cancer Center ( Site 0029), New York, New York

Stony Brook University-Cancer Center ( Site 0072), Stony Brook, New York

Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0063), Fargo, North Dakota

Altru Health System ( Site 0040), Grand Forks, North Dakota

Summa Health ( Site 4011), Akron, Ohio

University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0028), Cincinnati, Ohio

University Hospitals Cleveland Medical Center ( Site 0023), Cleveland, Ohio

OSU Brain and Spine Hospital ( Site 0016), Columbus, Ohio

Good Samaritan Regional Medical Center-Samaritan Pastega Regional Cancer Center ( Site 0082), Corvallis, Oregon

Thomas Jefferson University - Clinical Research Institute ( Site 0006), Philadelphia, Pennsylvania

Medical University of South Carolina-Hollings Cancer Center ( Site 0050), Charleston, South Carolina

Sanford Cancer Center ( Site 0075), Sioux Falls, South Dakota

Thompson Cancer Survival Center ( Site 0097), Knoxville, Tennessee

One Oncology - Tennessee Oncology ( Site 4019), Nashville, Tennessee

SCRI Oncology Partners ( Site 7001), Nashville, Tennessee

UT Southwestern Medical Center ( Site 0061), Dallas, Texas

Inova Schar Cancer Institute ( Site 0003), Fairfax, Virginia

Swedish Medical Center-Swedish Cancer Institute ( Site 0088), Seattle, Washington

Edwards Comprehensive Cancer Center ( Site 4015), Huntington, West Virginia

Clinica Adventista Belgrano-Oncology ( Site 2901), Caba., Buenos Aires

Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 2912), Caba, Buenos Aires

Instituto Alexander Fleming ( Site 2911), Ciudad Autónoma de Buenos Aires, Buenos Aires

Instituto de Investigaciones Clínicas Mar del Plata ( Site 2908), Mar del Plata, Buenos Aires

Fundacion Estudios Clinicos-Oncology ( Site 2907), Rosario, Santa Fe

Sanatorio Parque ( Site 2904), Rosario, Santa Fe

Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0203), Melbourne, Victoria

St Vincent's Hospital-Oncology Clinical Trials ( Site 0202), Melbourne, Victoria

One Clinical Research ( Site 0200), Nedlands, Western Australia

Antwerp University Hospital-Thoracic Oncology ( Site 0603), Edegem, Antwerpen

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi ( Site 0602), Yvoir, Namur

AZORG Campus Aalst-Moorselbaan ( Site 0604), Aalst, Oost-Vlaanderen

VITAZ ( Site 0600), Sint-Niklaas, Oost-Vlaanderen

CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA-Pesquisa Clínica ( Site 3007), Fortaleza, Ceara

Liga Norte Riograndense Contra o Câncer ( Site 3001), Natal., Rio Grande Do Norte

Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 3003), Porto Alegre, Rio Grande Do Sul

Hospital Nossa Senhora da Conceição ( Site 3002), Porto Alegre, Rio Grande Do Sul

Fundação Pio XII - Hospital de Câncer de Barretos ( Site 3004), Barretos, Sao Paulo

Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 3013), São José do Rio Preto, Sao Paulo

Instituto Nacional de Câncer - INCA ( Site 3000), Rio de Janeiro, Not set

Hospital Samaritano De Sao Paulo ( Site 3006), Sao Paulo, Not set

ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 3005), Sao Paulo, Not set

Cross Cancer Institute ( Site 0105), Edmonton, Alberta

William Osler Health System ( Site 0101), Brampton, Ontario

Princess Margaret Cancer Centre ( Site 0102), Toronto, Ontario

Centre Hospitalier de l'Université de Montréal ( Site 0104), Montréal, Quebec

McGill University Health Centre ( Site 0100), Montréal, Quebec

Orlandi Oncologia-Oncology ( Site 3102), Santiago, Region M. De Santiago

FALP-UIDO ( Site 3100), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile-Centro del Cáncer ( Site 3104), Santiago, Region M. De Santiago

Bradfordhill-Clinical Area ( Site 3103), Santiago, Region M. De Santiago

ONCOCENTRO APYS ( Site 3105), Viña del Mar, Valparaiso

CIMCA ( Site 3300), San José, San Jose

ICIMED ( Site 3301), San Jose, Not set

Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0700), Brno, Brno-mesto

Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni odd ( Site 0702), Ostrava, Ostrava Mesto

Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberkulozy ( Site 0701), Olomouc, Not set

Vseobecna fakultni nemocnice v Praze ( Site 0703), Praha 2, Not set

Rigshospitalet ( Site 0801), Copenhagen, Hovedstaden

Odense Universitetshospital ( Site 0800), Odense C, Syddanmark

North Estonia Medical Centre Foundation-Chemotherapy ( Site 0901), Tallinn, Harjumaa

Tartu University Hospital-Radiotherapy and oncology ( Site 0900), Tartu, Tartumaa

Tampereen yliopistollinen sairaala-Oncology ( Site 1001), Tampere, Pirkanmaa

Vaasan Keskussairaala-Department of Clinical Oncology ( Site 1004), Vaasa, Pohjanmaa

Oulun yliopistollinen sairaala-Oncology and Hematology ( Site 1003), Oulu, Pohjois-Pohjanmaa

Turku University Hospital-The Department of Pulmonary Medicine ( Site 1000), Turku, Varsinais-Suomi

Nouvel Hôpital Civil (NHC)-Service de pneumologie ( Site 1100), Strasbourg, Alsace

CHU Bordeaux Haut-Leveque ( Site 1106), Pessac, Aquitaine

Assistance Publique Hôpitaux de Marseille - Hôpital Nord ( Site 1108), Marseille, Bouches-du-Rhone

Centre Hospitalier Universitaire de Caen - Hôpital Côte de Nacre ( Site 1107), Caen, Calvados

Hôpital Arnaud de Villeneuve - CHU Montpellier ( Site 1102), Montpellier, Herault

Institut de Cancérologie de l'Ouest ( Site 1101), ANGERS cedex 02, Maine-et-Loire

CHU GABRIEL MONTPIED ( Site 1105), Clermont-Ferrand, Puy-de-Dome

Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 1104), Paris, Not set

Klinikum Esslingen-Klinik für Kardiologie und Pneumologie ( Site 1201), Esslingen, Baden-Wurttemberg

Asklepios Klinik Gauting GmbH-Oncology ( Site 1209), Gauting, Bayern

Klinikverbund Allgäu gGmbH ( Site 1205), Kempten, Bayern

Universitaetsklinikum Regensburg ( Site 1204), Regensburg, Bayern

Augusta-Kranken-Anstalt ( Site 1213), Bochum, Nordrhein-Westfalen

Gemeinschaftspraxis für Hämatologie und Onkologie Münster ( Site 1202), Münster, Nordrhein-Westfalen

Brüderkrankenhaus St. Josef Paderborn-Klinik für Hämatologie und Onkologie ( Site 1214), Paderborn, Nordrhein-Westfalen

SRH Wald-Klinikum Gera-Lungenkrebszentrum ( Site 1200), Gera, Thuringen

Helios Klinikum Emil von Behring Berlin-Zehlendorf-Lungenklinik Heckeshorn ( Site 1208), Berlin, Not set

Errikos Dunant Hospital Center-Fourth Department of Oncology and Clinical Trials Unit ( Site 1301), Athens, Attiki

THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1300), Athens, Attiki

European Interbalkan Medical Center-Oncology Department ( Site 1302), Thessaloniki, Not set

Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 1401), Kecskemét, Bacs-Kiskun

Pécsi Tudományegyetem Klinikai Központ-Onkoterápiás Intézet ( Site 1402), Pecs, Baranya

Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz - Pulmonologia Osztaly ( Site 1404), Gyor, Gyor-Moson-Sopron

Reformatus Pulmonologiai Centrum ( Site 1405), Törökbálint, Pest

Somogy Varmegyei Kaposi Mor Oktato Korhaz -Onkologiai Kozpont ( Site 1407), Kaposvár, Somogy

Tallaght University Hospital ( Site 3903), Dublin, Not set

CRO-IRCCS-Clinical Oncology ( Site 1510), Aviano, Friuli-Venezia Giulia

P.O. "S. Maria della Misericordia" Azienda Sanitaria Univers-Oncology Department ( Site 1506), Udine, Friuli-Venezia Giulia

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1504), Milan, Lombardia

ASST Grande Ospedale Metropolitano Niguarda-Oncologia Falck ( Site 1511), Milan, Milano

A.O.R.N. Ospedale dei Colli - Monaldi V.-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1508), Naples, Napoli

Instituto Tumori Giovanni Paolo II-SSD Oncologia Medica per la Patologia Toracica ( Site 1507), Bari, Puglia

POLICLINICO "G. RODOLICO"-UOC Oncologia Medica ( Site 1503), Catania, Sicilia

AO Santa Maria della Misericordia-Oncology Department ( Site 1501), Perugia, Umbria

Azienda Ospedaliera Santa Croce e Carle ( Site 1500), Cuneo, Not set

Azienda Ospedaliero Universitaria Maggiore della Carità ( Site 1502), Novara, Not set

St. Marianna University Hospital ( Site 3802), Kawasaki, Kanagawa

Kanagawa Cancer Center ( Site 3801), Yokohama, Kanagawa

Kindai University Hospital ( Site 3803), Osakasayama, Osaka

Hiroshima University Hospital ( Site 3804), Hiroshima, Not set

Chungbuk National University Hospital-Internal medicine ( Site 0402), Cheongju-si, Chungbuk

National Cancer Center-Lung Cancer Center ( Site 0403), Goyang-si, Kyonggi-do

Seoul National University Bundang Hospital-Medical Oncology ( Site 0404), Seongnam, Kyonggi-do

The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 0406), Suwon-si, Kyonggi-do

Keimyung University Dongsan Hospital CRC room 1 ( Site 0407), Daegu, Taegu-Kwangyokshi

Seoul National University Hospital ( Site 0400), Seoul, Not set

Asan Medical Center-Department of Oncology ( Site 0405), Seoul, Not set

Samsung Medical Center ( Site 0401), Seoul, Not set

RIGA EAST UNIVERSITY HOSPITAL ,Oncology Centre of Latvia ( Site 1600), Riga, Not set

Hospital of Lithuanian University of Health Sciences Kauno klinikos-Pulmonology ( Site 1701), Kaunas, Kauno Apskritis

National Cancer Institute-Department of Thoracic Surgery and Oncology ( Site 1700), Vilnius, Vilniaus Miestas

University Malaya Medical Centre ( Site 3502), Lembah Pantai, Kuala Lumpur

National Cancer Institute-Radiotherapy and Oncology ( Site 3506), Putrajaya, Kuala Lumpur

Hospital Tengku Ampuan Afzan ( Site 3504), Kuantan, Pahang

Hospital Pulau Pinang ( Site 3505), George Town, Pulau Pinang

Sarawak General Hospital ( Site 3500), Kuching, Sarawak

CIO - Centro de Inmuno-Oncología de Occidente ( Site 3403), Guadalajara, Jalisco

Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 3408), Monterrey, Nuevo Leon

Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 3402), Chihuahua, Not set

Mediadvance Clinical ( Site 3404), Chihuahua, Not set

Oaxaca Site Management Organization S.C. ( Site 3407), Oaxaca, Not set

Centro de Investigacion Clinica de Oaxaca ( Site 3401), Oaxaca, Not set

New Zealand Clinical Research (Christchurch) ( Site 0300), Christchurch, Canterbury

Harbour Cancer & Wellness ( Site 0301), Auckland, Not set

Akershus Universitetssykehus-Avdeling for lungesykdommer ( Site 1900), Lørenskog, Akershus

Drammen Sykehus, Vestre Viken HF ( Site 1903), Drammen, Buskerud

Stavanger Universitetssykehus ( Site 1901), Stavanger, Rogaland

Metro Davao Medical and Research Center ( Site 3602), Davao City, Davao Del Sur

ST. LUKE'S MEDICAL CENTER ( Site 3606), Quezon City, National Capital Region

CARDINAL SANTOS MEDICAL CENTER-Research Room ( Site 3601), San Juan City, Metro Manila, National Capital Region

Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2003), Bydgoszcz, Kujawsko-pomorskie

Krakowski Szpital Specjalistyczny im. Jana Pawła II-Oddział Kliniczny Chirurgii Klatki Piersiowej i ( Site 2011), Krakow, Malopolskie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2000), Warszawa, Mazowieckie

Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2001), Przemysl, Podkarpackie

Bialostockie Centrum Onkologii ( Site 2005), Bialystok, Podlaskie

Uniwersyteckie Centrum Kliniczne ( Site 2013), Gdansk, Pomorskie

Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemioterapii ( Site 2008), Olsztyn, Warminsko-mazurskie

Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 2002), Poznan, Wielkopolskie

Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 2703), Lisbon, Lisboa

Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2702), Porto, Not set

Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica ( Site 2202), Banska Bystrica, Banskobystricky Kraj

Univerzitná nemocnica Bratislava - Nemocnica Ružinov ( Site 2201), Bratislava, Bratislavsky Kraj

Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2401), L'Hospitalet de Llobregat, Barcelona

HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA-Medical Oncology ( Site 2403), Majadahonda, Madrid, Comunidad De

HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2402), Pozuelo de Alarcon, Madrid

Hospital Quirón Málaga ( Site 2405), Málaga, Malaga

Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 2400), Barcelona, Not set

Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2404), Sevilla, Not set

National Taiwan University Cancer Center (NTUCC) ( Site 0500), Taipei City, Taipei

Changhua Christian Hospital ( Site 0504), Changhua, Not set

National Taiwan University Hospital - Hsinchu branch ( Site 0501), Hsinchu, Not set

Taichung Veterans General Hospital-Chest ( Site 0503), Taichung, Not set

National Cheng Kung University Hospital-Clinical Trial Center ( Site 0505), Tainan, Not set

National Taiwan University Hospital-Oncology ( Site 0506), Taipei, Not set

Taipei Medical University Hospital ( Site 0502), Taipei, Not set

Medipol Mega Universite Hastanesi-oncology ( Site 2105), Stanbul, Istanbul

Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2107), Bornova, Izmir

Hacettepe Universite Hastaneleri-oncology hospital ( Site 2100), Ankara, Not set

Memorial Ankara Hastanesi-Medical Oncology ( Site 2103), Ankara, Not set

Liv Hospital Ankara-Oncology ( Site 2104), Ankara, Not set

Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 2101), Ankara, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2102), Istanbul, Not set

Conditions: Non-small Cell Lung Cancer

Learn More ›

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

NCT06692738

Recruiting

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/12/2025

Locations: Research Site, Tucson, Arizona +288 locations

Research Site, Tucson, Arizona

Research Site, Springdale, Arkansas

Research Site, Beverly Hills, California

Research Site, Glendale, California

Research Site, Los Alamitos, California

Research Site, Redlands, California

Research Site, San Francisco, California

Research Site, Walnut Creek, California

Research Site, West Haven, Connecticut

Research Site, Newark, Delaware

Research Site, Bay Pines, Florida

Research Site, Fort Lauderdale, Florida

Research Site, Gainesville, Florida

Research Site, Jacksonville, Florida

Research Site, Athens, Georgia

Research Site, Atlanta, Georgia

Research Site, Boise, Idaho

Research Site, Chicago, Illinois

Research Site, Decatur, Illinois

Research Site, Quincy, Illinois

Research Site, Waterloo, Iowa

Research Site, Lexington, Kentucky

Research Site, Louisville, Kentucky

Research Site, Alexandria, Louisiana

Research Site, Baton Rouge, Louisiana

Research Site, Covington, Louisiana

Research Site, Shreveport, Louisiana

Research Site, South Portland, Maine

Research Site, Baltimore, Maryland

Research Site, Bethesda, Maryland

Research Site, Detroit, Michigan

Research Site, Grand Rapids, Michigan

Research Site, Duluth, Minnesota

Research Site, Rochester, Minnesota

Research Site, Bridgeton, Missouri

Research Site, Columbia, Missouri

Research Site, Kansas City, Missouri

Research Site, Omaha, Nebraska

Research Site, Camden, New Jersey

Research Site, Buffalo, New York

Research Site, East Syracuse, New York

Research Site, Westbury, New York

Research Site, Cincinnati, Ohio

Research Site, Bend, Oregon

Research Site, Medford, Oregon

Research Site, Salem, Oregon

Research Site, Hershey, Pennsylvania

Research Site, York, Pennsylvania

Research Site, Sioux Falls, South Dakota

Research Site, Chattanooga, Tennessee

Research Site, Nashville, Tennessee

Research Site, Fort Worth, Texas

Research Site, Houston, Texas

Research Site, Kingwood, Texas

Research Site, Lubbock, Texas

Research Site, Round Rock, Texas

Research Site, Fairfax, Virginia

Research Site, Fredericksburg, Virginia

Research Site, Olympia, Washington

Research Site, Seattle, Washington

Research Site, Silverdale, Washington

Research Site, Spokane, Washington

Research Site, Tacoma, Washington

Research Site, Wenatchee, Washington

Research Site, Buenos Aires, Not set

Research Site, Caba, Not set

Research Site, La Plata, Not set

Research Site, Pilar, Not set

Research Site, Rosario, Not set

Research Site, Darlinghurst, Not set

Research Site, Hyde Park, Not set

Research Site, Southport, Not set

Research Site, Wollongong, Not set

Research Site, Innsbruck, Not set

Research Site, Krems, Not set

Research Site, Rankweil, Not set

Research Site, Wien, Not set

Research Site, Anderlecht, Not set

Research Site, Brussels, Not set

Research Site, Charleroi, Not set

Research Site, Kortrijk, Not set

Research Site, Sint-Niklaas, Not set

Research Site, Barretos, Not set

Research Site, Florianópolis, Not set

Research Site, Ijuí, Not set

Research Site, Londrina, Not set

Research Site, Porto Alegre, Not set

Research Site, Salvador, Not set

Research Site, Sao Paulo, Not set

Research Site, Taubaté, Not set

Research Site, Saint John, New Brunswick

Research Site, Sydney, Nova Scotia

Research Site, Hamilton, Ontario

Research Site, Sault Ste. Marie, Ontario

Research Site, Montreal, Quebec

Research Site, Montréal, Quebec

Research Site, Beijing, Not set

Research Site, Changchun, Not set

Research Site, Changde, Not set

Research Site, Changsha, Not set

Research Site, Chengdu, Not set

Research Site, Chongqing, Not set

Research Site, Dalian, Not set

Research Site, Guangzhou, Not set

Research Site, Hangzhou, Not set

Research Site, Harbin, Not set

Research Site, Hefei, Not set

Research Site, Jinan, Not set

Research Site, Kunming, Not set

Research Site, Linhai, Not set

Research Site, Linyi, Not set

Research Site, Nanchang, Not set

Research Site, Ningbo, Not set

Research Site, Shanghai, Not set

Research Site, Shenyang, Not set

Research Site, Shenzhen, Not set

Research Site, Taiyuan, Not set

Research Site, Tianjin, Not set

Research Site, Wenzhou, Not set

Research Site, Wuhan, Not set

Research Site, Xi'an, Not set

Research Site, Yangzhou, Not set

Research Site, Yueyang, Not set

Research Site, Zhengzhou, Not set

Research Site, Avignon, Not set

Research Site, La Rochelle Cedex, Not set

Research Site, Lyon, Not set

Research Site, Nimes, Not set

Research Site, Rennes, Not set

Research Site, Strasbourg Cedex, Not set

Research Site, Suresnes, Not set

Research Site, Toulon Cedex 9, Not set

Research Site, Bad Berka, Not set

Research Site, Berlin, Not set

Research Site, Esslingen, Not set

Research Site, Frankfurt, Not set

Research Site, Gauting, Not set

Research Site, Giessen, Not set

Research Site, Großhansdorf, Not set

Research Site, Hamburg, Not set

Research Site, Hannover, Not set

Research Site, Heidelberg, Not set

Research Site, Hemer, Not set

Research Site, Homburg, Not set

Research Site, Kassel, Not set

Research Site, Kiel, Not set

Research Site, Krefeld, Not set

Research Site, Köln, Not set

Research Site, Minden, Not set

Research Site, Moers, Not set

Research Site, München, Not set

Research Site, Regensburg, Not set

Research Site, Würzburg, Not set

Research Site, Budapest, Not set

Research Site, Debrecen, Not set

Research Site, Gyöngyös, Not set

Research Site, Győr, Not set

Research Site, Pécs, Not set

Research Site, Székesfehérvár, Not set

Research Site, Törökbálint, Not set

Research Site, Calicut, Not set

Research Site, Delhi, Not set

Research Site, Kolkata, Not set

Research Site, Madurai, Not set

Research Site, Mumbai, Not set

Research Site, Nashik, Not set

Research Site, New Delhi, Not set

Research Site, Pondicherry, Not set

Research Site, Surat, Not set

Research Site, Varanasi, Not set

Research Site, Firenze, Not set

Research Site, Monza, Not set

Research Site, Orbassano, Not set

Research Site, Padova, Not set

Research Site, Peschiera Del Garda, Not set

Research Site, Roma, Not set

Research Site, Amagasaki-shi, Not set

Research Site, Bunkyo-ku, Not set

Research Site, Chuo-ku, Not set

Research Site, Fukuoka-shi, Not set

Research Site, Hiroshima-shi, Not set

Research Site, Kawagoe-shi, Not set

Research Site, Kitaadachi-gun, Not set

Research Site, Kitakyushu-shi, Not set

Research Site, Kobe-shi, Not set

Research Site, Koto-ku, Not set

Research Site, Kumamoto-shi, Not set

Research Site, Matsusaka-shi, Not set

Research Site, Osaka-shi, Not set

Research Site, Osakasayama, Not set

Research Site, Ota-shi, Not set

Research Site, Saitama-shi, Not set

Research Site, Sendai-shi, Not set

Research Site, Shinjuku-ku, Not set

Research Site, Yokohama-shi, Not set

Research Site, Cheongju-si, Not set

Research Site, Incheon, Not set

Research Site, Seoul, Not set

Research Site, Suwon-si, Not set

Research Site, George Town, Not set

Research Site, Johor Bahru, Not set

Research Site, Kuala Lumpur, Not set

Research Site, Alkmaar, Not set

Research Site, Ede, Not set

Research Site, Groningen, Not set

Research Site, Leidschendam, Not set

Research Site, Veldhoven, Not set

Research Site, Zwolle, Not set

Research Site, Lima, Not set

Research Site, Biała Podlaska, Not set

Research Site, Białystok, Not set

Research Site, Bydgoszcz, Not set

Research Site, Bystra, Not set

Research Site, Poznań, Not set

Research Site, Warszawa, Not set

Research Site, Łódź, Not set

Research Site, San Juan, Not set

Research Site, Barcelona, Not set

Research Site, Las Palmas de Gran Canaria, Not set

Research Site, Lérida, Not set

Research Site, Madrid, Not set

Research Site, Majadahonda, Not set

Research Site, Sevilla, Not set

Research Site, Kaohsiung, Not set

Research Site, New Taipei City, Not set

Research Site, New Taipei, Not set

Research Site, Taichung, Not set

Research Site, Tainan City, Not set

Research Site, Taoyuan, Not set

Research Site, Bangkok, Not set

Research Site, Chiang Mai, Not set

Research Site, Dusit, Not set

Research Site, Nakhon Ratchasima, Not set

Research Site, Songkla, Not set

Research Site, Antalya, Not set

Research Site, Istanbul, Not set

Research Site, Yenimahalle, Not set

Research Site, Aberdeen, Not set

Research Site, Cambridge, Not set

Research Site, Edinburgh, Not set

Research Site, Exeter, Not set

Research Site, Greater London, Not set

Research Site, London, Not set

Research Site, Manchester, Not set

Research Site, Newcastle upon Tyne, Not set

Research Site, Preston, Not set

Research Site, Can Tho, Not set

Research Site, Hanoi, Not set

Research Site, Ho Chi Minh City, Not set

Research Site, Ho Chi Minh, Not set

Research Site, Vinh, Not set

Conditions: Non-small Cell Lung Cancer

Learn More ›

Browse by State

Non-Small Cell Lung Cancer clinical trials in Alabama

Non-Small Cell Lung Cancer clinical trials in Alaska

Non-Small Cell Lung Cancer clinical trials in Arizona

Non-Small Cell Lung Cancer clinical trials in Arkansas

Non-Small Cell Lung Cancer clinical trials in California

Non-Small Cell Lung Cancer clinical trials in Colorado

Non-Small Cell Lung Cancer clinical trials in Connecticut

Non-Small Cell Lung Cancer clinical trials in Delaware

Non-Small Cell Lung Cancer clinical trials in District of Columbia

Non-Small Cell Lung Cancer clinical trials in Florida

Non-Small Cell Lung Cancer clinical trials in Georgia

Non-Small Cell Lung Cancer clinical trials in Hawaii

Non-Small Cell Lung Cancer clinical trials in Idaho

Non-Small Cell Lung Cancer clinical trials in Illinois

Non-Small Cell Lung Cancer clinical trials in Indiana

Non-Small Cell Lung Cancer clinical trials in Iowa

Non-Small Cell Lung Cancer clinical trials in Kansas

Non-Small Cell Lung Cancer clinical trials in Kentucky

Non-Small Cell Lung Cancer clinical trials in Louisiana

Non-Small Cell Lung Cancer clinical trials in Maine

Non-Small Cell Lung Cancer clinical trials in Montana

Non-Small Cell Lung Cancer clinical trials in Nebraska

Non-Small Cell Lung Cancer clinical trials in Nevada

Non-Small Cell Lung Cancer clinical trials in New Hampshire

Non-Small Cell Lung Cancer clinical trials in New Jersey

Non-Small Cell Lung Cancer clinical trials in New Mexico

Non-Small Cell Lung Cancer clinical trials in New York

Non-Small Cell Lung Cancer clinical trials in North Carolina

Non-Small Cell Lung Cancer clinical trials in North Dakota

Non-Small Cell Lung Cancer clinical trials in Ohio

Non-Small Cell Lung Cancer clinical trials in Oklahoma

Non-Small Cell Lung Cancer clinical trials in Oregon

Non-Small Cell Lung Cancer clinical trials in Maryland

Non-Small Cell Lung Cancer clinical trials in Massachusetts

Non-Small Cell Lung Cancer clinical trials in Michigan

Non-Small Cell Lung Cancer clinical trials in Minnesota

Non-Small Cell Lung Cancer clinical trials in Mississippi

Non-Small Cell Lung Cancer clinical trials in Missouri

Non-Small Cell Lung Cancer clinical trials in Pennsylvania

Non-Small Cell Lung Cancer clinical trials in Rhode Island

Non-Small Cell Lung Cancer clinical trials in South Carolina

Non-Small Cell Lung Cancer clinical trials in South Dakota

Non-Small Cell Lung Cancer clinical trials in Tennessee

Non-Small Cell Lung Cancer clinical trials in Texas

Non-Small Cell Lung Cancer clinical trials in Utah

Non-Small Cell Lung Cancer clinical trials in Vermont

Non-Small Cell Lung Cancer clinical trials in Virginia

Non-Small Cell Lung Cancer clinical trials in Washington

Non-Small Cell Lung Cancer clinical trials in West Virginia

Non-Small Cell Lung Cancer clinical trials in Wisconsin

Non-Small Cell Lung Cancer clinical trials in Wyoming